Novel psychoactive substance use among treatment ‐seeking opiate users: The role of life events and psychiatric symptoms

ConclusionSynthetic cathinones might still substitute amphetamine‐derivatives, although these NPS are no longer legal. There is a need for the regular screening of psychiatric symptoms and the use of family therapy among participants on opioid substitution programs.

Source: Human Psychopharmacology: Clinical and Experimental - June 15, 2017 Category: Psychiatry Authors: M áté Kapitány‐Fövény, Judit Farkas, Patrícia Andrea Pataki, Anna Kiss, Janka Horváth, Róbert Urbán, Zsolt Demetrovics Tags: SPECIAL ISSUE ON NOVEL PSYCHOACTIVE SUBSTANCES Source Type: research